BML 4.92 Increased By ▲ 0.01 (0.2%)
BOP 14.49 Increased By ▲ 0.17 (1.19%)
CNERGY 7.02 Decreased By ▼ -0.04 (-0.57%)
CPHL 88.50 Increased By ▲ 0.31 (0.35%)
DCL 12.63 Increased By ▲ 0.19 (1.53%)
DGKC 192.50 Increased By ▲ 8.22 (4.46%)
FCCL 50.45 Increased By ▲ 0.45 (0.9%)
FFL 15.82 Increased By ▲ 0.13 (0.83%)
GCIL 27.96 Decreased By ▼ -0.40 (-1.41%)
HUBC 160.50 Increased By ▲ 1.65 (1.04%)
KEL 5.18 Increased By ▲ 0.12 (2.37%)
KOSM 6.35 Increased By ▲ 0.05 (0.79%)
LOTCHEM 21.99 Increased By ▲ 0.18 (0.83%)
MLCF 89.75 Increased By ▲ 3.80 (4.42%)
NBP 147.01 Increased By ▲ 0.14 (0.1%)
PAEL 42.89 Increased By ▲ 0.32 (0.75%)
PIAHCLA 20.00 Decreased By ▼ -0.20 (-0.99%)
PIBTL 10.22 Decreased By ▼ -0.01 (-0.1%)
POWER 14.89 Increased By ▲ 0.32 (2.2%)
PPL 184.09 Increased By ▲ 4.65 (2.59%)
PREMA 42.86 Increased By ▲ 3.90 (10.01%)
PRL 31.46 Decreased By ▼ -0.20 (-0.63%)
PTC 23.27 Increased By ▲ 0.32 (1.39%)
SNGP 118.70 Increased By ▲ 1.67 (1.43%)
SSGC 41.38 Decreased By ▼ -0.39 (-0.93%)
TELE 7.75 Increased By ▲ 0.10 (1.31%)
TPLP 9.74 Decreased By ▼ -0.03 (-0.31%)
TREET 22.52 Increased By ▲ 0.08 (0.36%)
TRG 56.85 Increased By ▲ 0.52 (0.92%)
WTL 1.40 Decreased By ▼ -0.01 (-0.71%)
BML 4.92 Increased By ▲ 0.01 (0.2%)
BOP 14.49 Increased By ▲ 0.17 (1.19%)
CNERGY 7.02 Decreased By ▼ -0.04 (-0.57%)
CPHL 88.50 Increased By ▲ 0.31 (0.35%)
DCL 12.63 Increased By ▲ 0.19 (1.53%)
DGKC 192.50 Increased By ▲ 8.22 (4.46%)
FCCL 50.45 Increased By ▲ 0.45 (0.9%)
FFL 15.82 Increased By ▲ 0.13 (0.83%)
GCIL 27.96 Decreased By ▼ -0.40 (-1.41%)
HUBC 160.50 Increased By ▲ 1.65 (1.04%)
KEL 5.18 Increased By ▲ 0.12 (2.37%)
KOSM 6.35 Increased By ▲ 0.05 (0.79%)
LOTCHEM 21.99 Increased By ▲ 0.18 (0.83%)
MLCF 89.75 Increased By ▲ 3.80 (4.42%)
NBP 147.01 Increased By ▲ 0.14 (0.1%)
PAEL 42.89 Increased By ▲ 0.32 (0.75%)
PIAHCLA 20.00 Decreased By ▼ -0.20 (-0.99%)
PIBTL 10.22 Decreased By ▼ -0.01 (-0.1%)
POWER 14.89 Increased By ▲ 0.32 (2.2%)
PPL 184.09 Increased By ▲ 4.65 (2.59%)
PREMA 42.86 Increased By ▲ 3.90 (10.01%)
PRL 31.46 Decreased By ▼ -0.20 (-0.63%)
PTC 23.27 Increased By ▲ 0.32 (1.39%)
SNGP 118.70 Increased By ▲ 1.67 (1.43%)
SSGC 41.38 Decreased By ▼ -0.39 (-0.93%)
TELE 7.75 Increased By ▲ 0.10 (1.31%)
TPLP 9.74 Decreased By ▼ -0.03 (-0.31%)
TREET 22.52 Increased By ▲ 0.08 (0.36%)
TRG 56.85 Increased By ▲ 0.52 (0.92%)
WTL 1.40 Decreased By ▼ -0.01 (-0.71%)
BR100 15,103 Increased By 140.9 (0.94%)
BR30 42,619 Increased By 540.8 (1.29%)
KSE100 148,196 Increased By 1704.8 (1.16%)
KSE30 45,271 Increased By 438.2 (0.98%)

Cancer is an extremely ancient disease and likely to exist as long as life does, according to an international team of researchers. Led by Thomas Bosch, an evolutionary biologist at Kiel University, the team discovered "naturally occurring" tumours in two different species of hydra, a group of small, tubular, tentacled animals whose body wall comprises two layers of cells separated by a gelatinous partition.
Evolutionarily very old, they are freshwater relatives of corals, sea anemones and jellyfish.
"Cancer is as old as multi-cellular life on Earth and will probably never be completely eradicated," Bosch said in the results of the team's study, published in the London-based scientific journal Nature Communications.
Caused by mutations to the DNA within cells, cancer is characterised by the uncontrolled multiplication of abnormal cells - creating a tumour - that have the ability to infiltrate and destroy normal body tissue.
The researchers said tumour-bearing hydra had "significantly reduced fitness" and that tumour cells introduced into healthy hydra could trigger tumour growth there as well.
"The invasive characteristic of cancer cells is also an evolutionarily old feature," Bosch concluded.
According to the researchers, the study of primordial animals such as hydra may provide a wealth of information on the mechanisms of cancerous tumour growth in humans.

Copyright Deutsche Presse-Agentur, 2014

Comments

Comments are closed.